Topiramate
- 1 May 1999
- Vol. 40 (s5), s71-s80
- https://doi.org/10.1111/j.1528-1157.1999.tb00922.x
Abstract
Six studies are cited to demonstrate that topiramate is effective as adjunctive therapy for refractory partial-onset seizures in adults. Subsequent studies indicate that topiramate is also effective as monotherapy in adults and as adjunctive therapy for partial-onset seizures in children, tonic-clonic seizures of nonfocal origin in children and adults, and drop attacks in Lennox-Gastaut syndrome. Adverse effects for adults and children included dizziness, fatigue, ataxia, confusion, somnolence, nephrolithiasis, paresthesia, and weight loss. More adverse effects were observed at higher doses. Topiramate exhibits rapid absorption, long duration of action, and minimal interaction with other antiepileptic drugs.Keywords
This publication has 47 references indexed in Scilit:
- Comparison of the Steady‐State Pharmacokinetics of Topiramate and Valproate in Patients with Epilepsy During Monotherapy and Concomitant TherapyEpilepsia, 1997
- Topiramate Monotherapy for Partial Onset SeizuresEpilepsia, 1997
- Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial EpilepsyEpilepsia, 1996
- Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial SeizuresEpilepsia, 1996
- Felbamate in the Treatment of Lennox‐Gastaut SyndromeEpilepsia, 1994
- Pathogenesis of Gastric Ulceration Produced by Acetazolamide in RatsDigestion, 1984
- Comparative studies on acetazolamide teratogenesis in pregnant rats, rabbits, and rhesus monkeysTeratology, 1981